Intraday calls for 01-02-11

Quotes with Resistance & Support

Market Information

Intraday calls for 01-02-11

Posted on: February 1st, 2011 at 8:34 am

Calls directly in ur mailbox daily. Intraday calls by email

Markets likely to open flat, resistance at 5550

If Markets shows some weakness later, go short on Dr. Reddy around 1635-1640 for a target of 1615 (book profits at 1620)

1.35pm – buy 5500 call at 98 target: 120. stoploss: 5410 – (continue to hold)

Nifty Index/Future Live Chart with RSI, MACD, Slow Stochastic – Click to view

SMS Alerts, no more page refreshes required

Now get Intraday, Pre-market and market hour calls instantly through SMS for as low as for 1500rs for 3 months

name

cell no.

682 Responses

{ ADD YOUR OWN }

Comment pages: 34 35 363738 39 40 41 42 Show all

Ravi Says:
February 1st, 2011
Posted at: 3:34 pm
can we buy jp associates now for long term in small quantity, it is possible to double in long term from present rate
CB Says:
February 1st, 2011
Posted at: 3:34 pm
Hi SAGAR, yes.. very true.
Nall's Says:
February 1st, 2011
Posted at: 3:39 pm
http://hindi.business-standard.com/storypage.php?autono=43300
any one can read this is in hindi... i am not that much fluent...
Geethika Says:
February 1st, 2011
Posted at: 3:42 pm
Hi CB, r u going to post any call on JISL
it almost went over sold what do u say
CA.Tejas Says:
February 1st, 2011
Posted at: 3:47 pm
What is the support & resistance level for NIFTY
ani Says:
February 1st, 2011
Posted at: 3:50 pm
Hi CB,
very gud aftrnoon...aftr so many days u cam ol..
i have purcahsed 5200 put @29 nad 5800 call @27...
please advice at price shld i sell both the call n put ...
is any how the market will go down frm here...thn i can keep 5200 put fr profit....or any trend to bounce frm here.....
regds
Geethika Says:
February 1st, 2011
Posted at: 3:52 pm
Greenply Industries Ltd.
, leader in plywood and laminate industry in India, has reported net sales of Rs. 3.16bn for the quarter ended December 31, 2010, registering a growth of 44.86 % as against Rs. 2.18bn posted in the same period of the last fiscal.

Net Profit for the quarter stood at Rs. 71,9mn as compared to Rs. 139.3mn posted in the corresponding quarter of last fiscal. This was primarily due to losses sustained at the new MDF and Laminate Units at Pantnagar, Uttarakhand and Nalagarh, Himachal Pradesh, amounting to Rs. 121.1mn on account of low capacity utilisations and product-mix. Earnings per share (diluted) for Q3FY11 stood at Rs. 2.98, as compared to Rs. 6.06 in Q3FY10.
Geethika Says:
February 1st, 2011
Posted at: 3:53 pm
Parenteral Drugs (India) Ltd.
, a leading player in intravenous fluid segment in India, has announced its results for the third quarter and nine months ended December 31, 2010 (Q3FY11).
On a consolidated basis, the company’s Q3FY11 net sales jumped 49.6% to Rs. 1.57bn from Rs. 1.04bn in the corresponding quarter previous year. Net profit grew by 125.4% to Rs. 18.28 crore in Q3FY11 from Rs. 8.11 crore in the corresponding quarter previous year while EBIDTA increased by 94.3% to Rs. 320mn from Rs. 164.7mn. Earnings per Share (fully diluted) stood at Rs. 7.07 for the quarter ended December 31, 2010.
CA.Tejas Says:
February 1st, 2011
Posted at: 3:54 pm
What is the news on Jain Irrigation... today down by 17% n All Airlines shares down... any specific news on it....
Geethika Says:
February 1st, 2011
Posted at: 3:55 pm
Syndicate Bank
a net profit of Rs. 2561.90 mn for the quarter ended December 31, 2010 as compared to Rs. 2057.40 mn for the quarter ended December 31, 2009.
Total Income has increased from Rs. 26769.50 mn for the quarter ended December 31, 2009 to Rs. 31568.40 mn for the quarter ended December 31, 2010.
CB Says:
February 1st, 2011
Posted at: 3:56 pm
Hi Akash, its possible
Hi Nall's, thanks for the link
Hi Geethika, its see institution selling. not really sure till where it could go
Hi CA.Tejas, support at 5390. resistance higher at 5550-5600
Hi ani, Good afternoon. yes, hold onto them. possible consolidate here for a week and selling could resume. hold both for now
CB Says:
February 1st, 2011
Posted at: 3:57 pm
Hi Geethika, thanks for the update
Hi CA.Tejas, yes, institutional selling seen in the stock.
Geethika Says:
February 1st, 2011
Posted at: 3:58 pm
Glenmark Pharma Q3 cons net profit up 16%
ani Says:
February 1st, 2011
Posted at: 3:59 pm
Hi CB,
shld nt i keep any price fr selling the both call n put..
regds
Ravi Says:
February 1st, 2011
Posted at: 4:00 pm
can we buy jp associates now for long term in small quantity, it is possible to double in long term from present rate.
Geethika Says:
February 1st, 2011
Posted at: 4:00 pm
APL apollo tubes
The Company’s operational revenues increased by 72.1% to Rs. 2.50bn as compared to Rs. 1.45bn during Q3FY10
Net profit was up by 54.7% to Rs. 130.1mn as compared to Rs. 84.1mn during Q3FY10; EPS was Rs. 6.41 (up 54.46%)